Why the study?
The study was conducted to illustrate efforts, mainly in the regulatory and public procurement arena, and present common challenges and solutions to improve exclusive access to validated automated blood pressure measuring devices in primary care within the HEARTS in the Americas initiative.
Successful implementation of validated automated blood pressure devices in primary care requires robust regulatory frameworks and comprehensive multi-stakeholder strategies.
Answers are grounded in this paper and cite their sources.
Validated BP device regulations may warrant policy attention; leaves open prospective studies of multi-stakeholder implementation.
The aim of the HEARTS in the Americas initiative is to promote the adoption of global best practices in the prevention and control of cardiovascular diseases, and improve the control of hypertension. HEARTS is being implemented in 21 countries and a diverse set of actions and measures are in progress to improve exclusive access in primary health care facilities to automated blood pressure measuring devices that have been validated for accuracy. The purpose of this manuscript is to illustrate these efforts, mainly in the regulatory and public procurement arena, and to present information on common challenges and solutions identified. Examples from six countries confirm the need for not only a robust regulatory framework to increase availability of validated automated blood pressure measuring devices but also a comprehensive strategic approach that involves relevant stakeholders, includes a multi-pronged approach and is associated with a national program to prevent and control non communicable diseases.
No takes yet. Share an insight, caveat, or question.
Lombardi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: